Skip to Content

CHC Healthcare Group 4164

Morningstar Rating
TWD 56.00 −0.40 (0.71%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

4164 is trading at a 18% discount.
Price
TWD 56.67
Fair Value
TWD 16.54
Uncertainty
High
1-Star Price
TWD 82.56
5-Star Price
TWD 35.60
Economic Moat
Pyty
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 4164 is a good fit for your portfolio.

Trading Information

Previous Close Price
TWD 56.60
Day Range
TWD 56.0056.60
52-Week Range
TWD 52.0075.60
Bid/Ask
TWD 56.00 / TWD 56.30
Market Cap
TWD 9.32 Bil
Volume/Avg
268,000 / 927,994

Key Statistics

Price/Earnings (Normalized)
25.47
Price/Sales
2.70
Dividend Yield (Trailing)
3.49%
Dividend Yield (Forward)
3.49%
Total Yield
3.49%

Company Profile

CHC Healthcare Group is a Taiwan based company engaged in the trading of pharmaceutical products and the sale, leasing, installation, and repair of medical instruments. It is engaged in the distribution of radiotherapy equipment, including equipment that is used in the treatment of radiation oncology, ophthalmology, dentistry, and neuroscience. It also provides medical equipment consulting for hospitals and clinics. It earns revenues from the sale of drugs, sale of medical instruments, and repairs maintenance and other services.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Small Core
Total Number of Employees
160

Comparables

Valuation

Metric
4164
GMPC
6838
Price/Earnings (Normalized)
25.47
Price/Book Value
1.456.33
Price/Sales
2.70214.54
Price/Cash Flow
9.86
Price/Earnings
4164
GMPC
6838

Financial Strength

Metric
4164
GMPC
6838
Quick Ratio
2.204.84
Current Ratio
3.041.854.99
Interest Coverage
7.05−71.54
Quick Ratio
4164
GMPC
6838

Profitability

Metric
4164
GMPC
6838
Return on Assets (Normalized)
3.14%7.16%−20.70%
Return on Equity (Normalized)
6.72%10.42%−30.97%
Return on Invested Capital (Normalized)
4.01%−30.85%
Return on Assets
4164
GMPC
6838
See how this stock stacks up to its competitors with Morningstar Investor

Medical Distribution Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MCK
McKesson CorpMqjmtlhyySfbmnv$69.9 Bil
COR
Cencora IncRdrdcmypVjwxvw$47.4 Bil
CAH
Cardinal Health IncHbchwkcTrjdgf$25.2 Bil
SHTDF
Sinopharm Group Co LtdXyyyz$8.6 Bil
SHTDY
Sinopharm Group Co Ltd ADRLdbldw$8.6 Bil
SHPMY
Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class HPdwvkr$8.2 Bil
SHPMF
Shanghai Pharmaceuticals Holding Co Ltd Class HVxntf$8.1 Bil
AMFPF
Amplifon SpA Az nom Post FrazionamentoVjbvt$7.6 Bil
MAHLY
Medipal Holdings Corp ADRQkns$3.3 Bil
MEPDF
Medipal Holdings CorpTynwd$3.3 Bil

Sponsor Center